pharmaceutical market
Sun Pharma’s $11.75 Billion Acquisition of Organon: A Game Changer
Sun Pharma has made headlines with its $11.75 billion acquisition of Organon, marking a significant step in the biopharma industry.
Sun Pharma Acquires US-Based Organon in $12 Billion All-Cash Deal
Sun Pharma has acquired US-based Organon for $12 billion, marking a significant growth opportunity in the pharmaceutical market.
Eli Lilly’s Market Share Declines as Novo Nordisk Maintains Position
Eli Lilly’s market share is declining in India due to generic weight-loss drugs, while Novo Nordisk maintains a stable position amidst competition.